Table 3.
Mechanically derived ADSC-SVF human tendinopathy and tendon injury.
| Authors | Injury | ADSC-SVF Provenience | ADSC-SVF Delivery | Device Used | Investigation | Outcomes |
|---|---|---|---|---|---|---|
| Striano et al. [56] |
Partial thickness Rotator cuff tear | Autologous from thigh area | Intralesional-injection | Lipogems | Clinical (ASES score, NPRT) | Significant improvements in pain, function and quality of life |
| Albano et al. [57] | Chronic achilles’ tendinopathy | Autologous, derived from abdomen | Intralesional-injection | Hy-tissue SVF (Fastkit) | Clinical (VAS) Radiological (MRI, US) |
Significant decrease VAS and an increased tendon thickness |
| Usuelli et al. [58] | Chronic achilles’ tendinopathy | Autologous, derived from abdomen | Intralesional-injection | Hy-tissue SVF (Fastkit) | Clinical (VAS, Visa-A, AOFAS) | Immediate benefits for VAS, Visa-A, AOFAS score |
ADSC (Adipose-Derived Stem Cell); SVF (Stromal Vascular Fraction); VAS (Visual Analogue Scale); MRI (Magnetic Resonance Imaging); American Shoulder and Elbow Surgeon [ASES] Score; Numeric Pain Rating Scale (NPRT), Victorian Institute of Sport Assessment-Achilles score (VISA-A); American Orthopaedic Foot and Ankle score (AOFAS).